Solutions
- Research Type
  - Fundamental Equity ResearchGain a comprehensive view of global themes, industries, and companies.
  - ETF Data & AnalyticsThe data and analytics you need to navigate the ETF universe.
  - ETF & Mutual Fund ResearchA forward focused, holistic approach to fund insights.
  - Forensic Accounting ResearchUnderstand implications of public company financial reporting.
  - Public Policy ResearchIdentify opportunity and risks driven by public policy.
  - Technical ResearchGiving you confidence to navigate any market cycle.
  - Legal ResearchReal-time insights on legal themes, cases, and regulatory events.
- Client Type
  - Wealth ManagementFull-service Broker-Dealers, Online Broker-Dealers, Wealth Management Firms, Private Banks, RIAs
  - Institutional InvestorsHedge Funds, Asset Managers, Pension Funds, Sovereign Wealth Funds, Private Equity, Family Offices
  - Financial AdvisorsFinancial Advisors, Relationship Managers, Wealth Managers
  - Individual InvestorsSelf-directed individual investors
Insights
About CFRA
Login

Solutions
- Research Type
  - Fundamental Equity ResearchGain a comprehensive view of global themes, industries, and companies.
  - ETF Data & AnalyticsThe data and analytics you need to navigate the ETF universe.
  - ETF & Mutual Fund ResearchA forward focused, holistic approach to fund insights.
  - Forensic Accounting ResearchUnderstand implications of public company financial reporting.
  - Public Policy ResearchIdentify opportunity and risks driven by public policy.
  - Technical ResearchGiving you confidence to navigate any market cycle.
  - Legal ResearchReal-time insights on legal themes, cases, and regulatory events.
- Client Type
  - Wealth ManagementFull-service Broker-Dealers, Online Broker-Dealers, Wealth Management Firms, Private Banks, RIAs
  - Institutional InvestorsHedge Funds, Asset Managers, Pension Funds, Sovereign Wealth Funds, Private Equity, Family Offices
  - Financial AdvisorsFinancial Advisors, Relationship Managers, Wealth Managers
  - Individual InvestorsSelf-directed individual investors
Insights
About CFRA
Login

Research, Fundamental

European Pharma: Top Picks as Growth Slows; New Launches and Core Products are Key

Wan Nurhayati, Equity Analyst

09 March 2023

Summary

With the conclusion of Q4 2022 results reporting period, we look back at the overall 2022 financial performance for European Pharma under our coverage and how they fared against consensus estimates, as well as the outlook for 2023.

Want to learn more? Download the Report.

Solutions

Fundamental Equity Research

Gain a comprehensive view of global themes, industries, and companies.

Public Policy Research

Identify opportunity and risks driven by public policy.

Forensic Accounting Research

Understand implications of public company financial reporting.

Related Insights

Health Care REITs Poised for Healthy Returns

The aging US population and increasing healthcare expenditures...